Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip W Harvey

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Applied Toxicology : JAT|September 17, 2003
Parabens, oestrogenicity, underarm cosmetics and breast cancer: a perspective on a hypothesisPhilip W Harvey
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Adrenocortical endocrine disruptionPhilip W Harvey
Journal of Applied Toxicology : JAT|November 19, 2011
Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specificPhilip W Harvey
Journal of Applied Toxicology : JAT|April 28, 2005
Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessmentsPhilip W Harvey
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 25, 2005
Comment on developmental toxicity evaluation of butylparaben in Sprague-Dawley ratsPhilip W Harvey
Toxicologic Pathology|October 6, 2011
Prolactin-induced mammary tumorigenesis is not a rodent-specific responsePhilip W Harvey
Journal of Applied Toxicology : JAT|September 5, 2002
Approaches to the assessment of toxicity data with endpoints related to endocrine disruptionPhilip W Harvey, Ian Johnson
Journal of Applied Toxicology : JAT|August 6, 2010
Adrenocortical hypertrophy: establishing cause and toxicological significancePhilip W Harvey, Catherine Sutcliffe
Journal of Applied Toxicology : JAT|June 24, 2004
Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women?Philip W Harvey, Philippa Darbre
Best Practice & Research. Clinical Endocrinology & Metabolism|March 9, 2006
Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human healthPhilip W Harvey, David J Everett
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Applied Toxicology : JAT|September 17, 2003
Parabens, oestrogenicity, underarm cosmetics and breast cancer: a perspective on a hypothesisPhilip W Harvey
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Adrenocortical endocrine disruptionPhilip W Harvey
Journal of Applied Toxicology : JAT|November 19, 2011
Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specificPhilip W Harvey
Journal of Applied Toxicology : JAT|April 28, 2005
Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessmentsPhilip W Harvey
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|February 25, 2005
Comment on developmental toxicity evaluation of butylparaben in Sprague-Dawley ratsPhilip W Harvey
Toxicologic Pathology|October 6, 2011
Prolactin-induced mammary tumorigenesis is not a rodent-specific responsePhilip W Harvey
Journal of Applied Toxicology : JAT|September 5, 2002
Approaches to the assessment of toxicity data with endpoints related to endocrine disruptionPhilip W Harvey, Ian Johnson
Journal of Applied Toxicology : JAT|August 6, 2010
Adrenocortical hypertrophy: establishing cause and toxicological significancePhilip W Harvey, Catherine Sutcliffe
Journal of Applied Toxicology : JAT|June 24, 2004
Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women?Philip W Harvey, Philippa Darbre
Best Practice & Research. Clinical Endocrinology & Metabolism|March 9, 2006
Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human healthPhilip W Harvey, David J Everett
Pageof 2